Medovex Corp. Business Finance Contracts & Agreements

96 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Common Stock Purchase Warrant Agreement between H-Cyte, Inc. and Holder
Warrant Agreements
Medovex Corp.
Biotechnology
2023
H-Cyte, Inc. 8.0% Convertible Promissory Note Agreement
Note Agreements
Medovex Corp.
Biotechnology
NY
2023
Common Stock Purchase Warrant Agreement between H-Cyte, Inc. and Holder
Warrant Agreements
Medovex Corp.
Biotechnology
2023
H-Cyte, Inc. 8.0% Convertible Promissory Note Agreement
Note Agreements
Medovex Corp.
Biotechnology
NY
2023
H-Cyte, Inc. $100,000 Promissory Note Agreement (June 8, 2022)
Note Agreements
Medovex Corp.
Biotechnology
2022
H-Cyte Inc. 10% Convertible Redeemable Note Agreement with ONE44 Capital LLC (Due June 8, 2023)
Note Agreements
Medovex Corp.
Biotechnology
NV
2022
H-Cyte Inc. 10% Convertible Redeemable Note Due June 7, 2023 (with Fast Capital, LLC)
Note Agreements
Medovex Corp.
Biotechnology
CA
2022
Amended and Restated Debt Conversion Agreement between H-Cyte, Inc. and Investors (April 29, 2022)
Financing Agreements
Medovex Corp.
Biotechnology
FL
2022
H-Cyte, Inc. Warrant Agreement for Purchase of Common Stock by Holder
Warrant Agreements
Medovex Corp.
Biotechnology
FL
2022
H-Cyte, Inc. Warrant Agreement for Purchase of Common Stock – [Holder]
Warrant Agreements
Medovex Corp.
Biotechnology
FL
2022
Second Closing Bring Down Agreement among H-Cyte, Inc., FWHC Bridge, LLC, and Additional Purchasers
Note Agreements
Medovex Corp.
Biotechnology
FL
2021
Secured Convertible Promissory Note between Medovex, LLC and Medovex Corp. dated April 2, 2021
Note Agreements
Medovex Corp.
Biotechnology
FL
2021
Contribution Agreement between Medovex Corp. and Medovex, LLC for DenerveX Device Assets
Contribution Agreements
Medovex Corp.
Biotechnology
DE
2021
H-CYTE, Inc. Secured Convertible Note Purchase Agreement with FWHC Bridge, LLC and Additional Purchasers (April 1, 2021)
Note Agreements
Medovex Corp.
Biotechnology
NV
2021
H-Cyte, Inc. Secured Convertible Promissory Note with [Purchaser] Dated [Date], 2021
Note Agreements
Medovex Corp.
Biotechnology
NV
2021
H-CYTE, Inc. Series A Preferred Stock Rights Offering Subscription Form
Subscription Agreements
Medovex Corp.
Biotechnology
2020
First Amendment to 12% Senior Secured Convertible Note between H-CYTE, INC. and FWHC Bridge, LLC
Note Agreements
Medovex Corp.
Biotechnology
DE
2020
Amendment to Employment Agreement between H-Cyte, Inc. and William E. Horne (March 2020)
Modification Agreements
Medovex Corp.
Biotechnology
2020
Intellectual Property Security Agreement between H-CYTE, INC. and FWHC BRIDGE, LLC (April 17, 2020)
Security Agreements
Medovex Corp.
Biotechnology
2020
Security Agreement between H-CYTE, Inc. and Subsidiaries and FWHC Bridge, LLC, dated April 17, 2020
Security Agreements
Medovex Corp.
Biotechnology
FL
2020
H-Cyte, Inc. Warrant Agreement for Purchase of Common Stock with [Holder], Dated April 2020
Warrant Agreements
Medovex Corp.
Biotechnology
FL
2020
H-Cyte, Inc. Secured Convertible Promissory Note with [Purchaser] dated [Date]
Note Agreements
Medovex Corp.
Biotechnology
NV
2020
H-CYTE, Inc. Secured Convertible Note and Warrant Purchase Agreement with FWHC Bridge, LLC and Other Purchasers (April 17, 2020)
Note Agreements
Medovex Corp.
Biotechnology
DE
2020
Amended and Restated Demand Promissory Note between H-Cyte, Inc. and FWHC Bridge, LLC dated April 9, 2020
Note Agreements
Medovex Corp.
Biotechnology
FL
2020
Demand Promissory Note between H-CYTE, INC. and FWHC BRIDGE, LLC dated March 27, 2020
Note Agreements
Medovex Corp.
Biotechnology
FL
2020
H-CYTE, INC. Investors’ Rights Agreement with Series D Preferred Stock Investors (November 15, 2019)
Investor Rights Agreements
Medovex Corp.
Biotechnology
NV
2019
Right of First Refusal and Co-Sale Agreement among H-Cyte, Inc., Investors, and Key Holders (November 15, 2019)
Investor Rights Agreements
Medovex Corp.
Biotechnology
NV
2019
Loan Agreement between H-CYTE Inc. and Horne Management, LLC dated October 28, 2019
Loan Agreements
Medovex Corp.
Biotechnology
FL
2019
Securities Purchase Agreement between Innoveren Scientific, Inc. and Purchasers (2024)
Purchase Agreements
Medovex Corp.
Biotechnology
NY
2024
Securities Purchase Agreement between Innoveren Scientific, Inc. and Purchasers (February 24, 2024)
Purchase Agreements
Medovex Corp.
Biotechnology
NY
2024
H-Cyte, Inc. Securities Purchase Agreement with Investors for Convertible Promissory Notes and Warrants
Purchase Agreements
Medovex Corp.
Biotechnology
NY
2023
H-Cyte, Inc. Securities Purchase Agreement with Investors (Convertible Notes and Warrants)
Purchase Agreements
Medovex Corp.
Biotechnology
NY
2023
Securities Purchase Agreement between H-Cyte, Inc. and Purchasers (September 2022)
Purchase Agreements
Medovex Corp.
Biotechnology
NY
2022
Securities Purchase Agreement between H-Cyte, Inc. and Purchasers (June 8, 2022)
Purchase Agreements
Medovex Corp.
Biotechnology
NY
2022
Securities Purchase Agreement between H-CYTE INC. and ONE44 CAPITAL, LLC dated June 8, 2022
Purchase Agreements
Medovex Corp.
Biotechnology
NV
2022
Securities Purchase Agreement between H-CYTE INC. and FAST CAPITAL, LLC dated June 7, 2022
Purchase Agreements
Medovex Corp.
Biotechnology
CA
2022
Standby Purchase Agreement between H-CYTE, INC. and Standby Purchasers (2020)
Purchase Agreements
Medovex Corp.
Biotechnology
FL
2020
Standby Purchase Agreement between H-CYTE, INC. and Standby Purchasers (2020)
Purchase Agreements
Medovex Corp.
Biotechnology
FL
2020
Absolute Guaranty of Payment and Performance by H-Cyte Management LLC, Lung Institute Tampa, LLC, Cognitive Health Institute Tampa, LLC, and Medovex Corp. for the Benefit of...
Guaranty Agreements
Medovex Corp.
Biotechnology
FL
2020
Securities Purchase Agreement between H-Cyte, Inc. and Purchasers (Series D Preferred Stock and Warrants)
Purchase Agreements
Medovex Corp.
Biotechnology
FL
2019